X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2421) 2421
Book Review (418) 418
Publication (173) 173
Newsletter (14) 14
Conference Proceeding (10) 10
Book Chapter (4) 4
Dissertation (4) 4
Magazine Article (4) 4
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2311) 2311
humans (2238) 2238
male (1578) 1578
female (1528) 1528
pancreatectomy - adverse effects (1483) 1483
surgery (1447) 1447
middle aged (1369) 1369
aged (1140) 1140
adult (963) 963
pancreatectomy (912) 912
pancreatic neoplasms - surgery (887) 887
treatment outcome (866) 866
pancreatectomy - methods (744) 744
gastroenterology & hepatology (694) 694
retrospective studies (652) 652
pancreaticoduodenectomy (579) 579
risk factors (453) 453
aged, 80 and over (451) 451
abridged index medicus (446) 446
pancreatic neoplasms - pathology (445) 445
medicine & public health (407) 407
resection (407) 407
time factors (402) 402
distal pancreatectomy (374) 374
pancreatic cancer (371) 371
cancer (369) 369
pancreatic neoplasms - mortality (363) 363
pancreas (352) 352
pancreatic fistula - etiology (346) 346
pancreaticoduodenectomy - adverse effects (344) 344
mortality (332) 332
complications (314) 314
gastroenterology (314) 314
pancreatectomy - mortality (301) 301
analysis (269) 269
follow-up studies (267) 267
management (255) 255
fistula (252) 252
postoperative complications - etiology (232) 232
prognosis (221) 221
risk assessment (216) 216
survival (210) 210
survival rate (208) 208
adenocarcinoma (206) 206
oncology (205) 205
postoperative complications (204) 204
adolescent (203) 203
international study-group (202) 202
health aspects (198) 198
young adult (198) 198
morbidity (197) 197
pancreas - surgery (196) 196
outcomes (195) 195
prospective studies (193) 193
length of stay (179) 179
risk-factors (177) 177
gastroenterology and hepatology (173) 173
animals (164) 164
pancreatic fistula (164) 164
adenocarcinoma - surgery (162) 162
pancreatic fistula - prevention & control (161) 161
pancreatic neoplasms - therapy (159) 159
pancreatic diseases - surgery (157) 157
care and treatment (155) 155
experience (155) 155
survival analysis (153) 153
neoplasm staging (152) 152
postoperative complications - epidemiology (151) 151
postoperative complications - prevention & control (148) 148
abdominal surgery (146) 146
pancreatitis - surgery (146) 146
tomography, x-ray computed (145) 145
multivariate analysis (143) 143
hepatology (139) 139
laparoscopy (139) 139
laparoscopy - adverse effects (137) 137
tumors (136) 136
pancreaticoduodenectomy - methods (131) 131
carcinoma (130) 130
pancreatitis (129) 129
endocrinology & metabolism (128) 128
ductal adenocarcinoma (126) 126
chemotherapy (122) 122
carcinoma, pancreatic ductal - surgery (121) 121
reoperation (118) 118
disease-free survival (116) 116
drainage (116) 116
diabetes mellitus - etiology (114) 114
splenectomy (114) 114
chemotherapy, adjuvant (113) 113
diabetes (113) 113
incidence (110) 110
pancreatic neoplasms - diagnosis (110) 110
postoperative complications - mortality (104) 104
adenocarcinoma - mortality (103) 103
patient selection (102) 102
original (100) 100
cohort studies (99) 99
chronic disease (97) 97
kaplan-meier estimate (97) 97
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2157) 2157
Russian (70) 70
French (55) 55
German (34) 34
Italian (26) 26
Japanese (23) 23
Chinese (19) 19
Hungarian (11) 11
Czech (10) 10
Spanish (9) 9
Romanian (8) 8
Slovak (5) 5
Swedish (4) 4
Polish (3) 3
Portuguese (3) 3
Norwegian (2) 2
Ukrainian (2) 2
Danish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 10/2017, Volume 35, Issue 29, pp. 3330 - 3337
Journal Article
Gastroenterology, ISSN 0016-5085, 2011, Volume 141, Issue 4, pp. 1254 - 1263
Background & Aims Treatment of patients with necrotizing pancreatitis has become more conservative and less invasive, but there are few data from prospective... 
Gastroenterology and Hepatology | Inflammation | Treatment | Clinical Trial | Pancreas | Surgery | MORTALITY | ABDOMINAL COMPARTMENT SYNDROME | GUIDELINES | SURGICAL-MANAGEMENT | SINGLE-CENTER | ORGAN FAILURE | NECROSECTOMY | NECROSIS | RETROPERITONEAL APPROACH | EXPERIENCE | GASTROENTEROLOGY & HEPATOLOGY | Endoscopy - mortality | Multiple Organ Failure - mortality | Prospective Studies | Debridement - mortality | Drainage - adverse effects | Humans | Middle Aged | Male | Pancreas - microbiology | Tomography, X-Ray Computed | Patient Selection | Anti-Bacterial Agents - therapeutic use | Netherlands | Time Factors | Catheterization - mortality | Drainage - methods | Adult | Female | Pancreatitis, Acute Necrotizing - microbiology | Odds Ratio | Pancreatitis, Acute Necrotizing - diagnostic imaging | Pancreas - diagnostic imaging | Pancreatitis, Acute Necrotizing - pathology | Pancreatectomy - adverse effects | Severity of Illness Index | Risk Assessment | Risk Factors | Emergencies | Pancreas - pathology | Pancreatitis, Acute Necrotizing - mortality | Linear Models | Logistic Models | Treatment Outcome | Chi-Square Distribution | Pancreatitis, Acute Necrotizing - therapy | Pancreas - surgery | Pancreatectomy - mortality | Randomized Controlled Trials as Topic | Multiple Organ Failure - etiology | Drainage - mortality | Catheterization - adverse effects | Aged | Endoscopy - adverse effects | Nutritional Support | Debridement - adverse effects | Medical colleges | CT imaging | Conservatism | Analysis | Medical societies | Patient outcomes | Pancreatitis | Physiological aspects | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
JAMA Surgery, ISSN 2168-6254, 08/2016, Volume 151, Issue 8, pp. e161137 - e161137
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 2, pp. 296 - 303
Purpose A challenge in borderline resectable pancreatic cancer (BRPC) management is the high rate of positive posterior margins (PM). Stereotactic body... 
Radiology | Hematology, Oncology and Palliative Medicine | TRIAL | PROGNOSTIC-FACTORS | ONCOLOGY | DUCTAL ADENOCARCINOMA | LONG-TERM SURVIVAL | RADIOTHERAPY | OUTCOMES | VASCULAR RECONSTRUCTION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RESECTION MARGINS | CHEMOTHERAPY | Leucovorin - administration & dosage | Chemoradiotherapy - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Pancreatic Neoplasms - diagnosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Radiosurgery - adverse effects | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Camptothecin - administration & dosage | Dose Fractionation | Female | Radiosurgery - methods | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Chemoradiotherapy - methods | Pancreatectomy | Radiation Injuries - diagnosis | Treatment Outcome | Radiation Injuries - etiology | Radiotherapy, Adjuvant - methods | Aged | Longitudinal Studies | Organoplatinum Compounds - adverse effects | Pancreatic Neoplasms - therapy | Oncology, Experimental | Pancreatic cancer | Radiation | Clinical trials | Research | Radiotherapy | Cancer | Index Medicus | PATIENTS | NEOPLASMS | CLINICAL TRIALS | CITROVORUM FACTOR | GY RANGE 01-10 | PANCREAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | GY RANGE 10-100
Journal Article
European Journal of Cancer, ISSN 0959-8049, 10/2018, Volume 102, pp. 95 - 102
The current trial assessed whether the addition of cisplatin and capecitabine to the nab-paclitaxel–gemcitabine backbone is feasible and active against... 
Locally advanced disease | Chemotherapy | PAXG | Pancreatic cancer | Borderline resectable disease | SURVIVAL | FOLFIRINOX | ONCOLOGY | RESECTION | REGIMEN | OUTCOMES | CANCER | Capecitabine - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Chemoradiotherapy, Adjuvant | Carcinoma, Pancreatic Ductal - surgery | Cisplatin - administration & dosage | Pancreatic Neoplasms - drug therapy | Young Adult | Neoadjuvant Therapy - mortality | Albumins - adverse effects | Time Factors | Adult | Carcinoma, Pancreatic Ductal - mortality | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Chemotherapy, Adjuvant | Paclitaxel - administration & dosage | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Pancreatectomy | Paclitaxel - adverse effects | Albumins - administration & dosage | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - drug therapy | Capecitabine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Progression-Free Survival | Adolescent | Cisplatin - adverse effects | Italy | Aged | Deoxycytidine - analogs & derivatives | Antimitotic agents | Adenocarcinoma | Product development | Antineoplastic agents | Cancer | Backbone | Carbohydrates | Gemcitabine | Toxicity | Disease control | Patients | Survival | Cisplatin | Pathology | Randomization | Paclitaxel | Solid tumors | Pancreas | Tumors | Index Medicus
Journal Article
Journal of Hepato‐Biliary‐Pancreatic Sciences, ISSN 1868-6974, 08/2016, Volume 23, Issue 8, pp. 497 - 507
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 21, pp. 2014 - 2022
Journal Article
Trials, ISSN 1745-6215, 2016, Volume 17, Issue 1, pp. 127 - 127
Pancreatic cancer is the fourth largest cause of cancer death in the United States and Europe with over 100,000 deaths per year in Europe alone. The overall... 
(Borderline) resectable pancreatic cancer | Intention to treat | Overall survival | Explorative laparotomy | Preoperative radiochemotherapy | MEDICINE, RESEARCH & EXPERIMENTAL | PROGNOSTIC-FACTORS | LONG-TERM SURVIVAL | ADENOCARCINOMA | CURATIVE RESECTION | ADJUVANT CHEMORADIATION | CHEMOTHERAPY | PHASE-II TRIAL | THERAPY | CONCURRENT RADIATION | FULL-DOSE GEMCITABINE | Humans | Clinical Protocols | Chemoradiotherapy, Adjuvant - adverse effects | Chemoradiotherapy, Adjuvant - mortality | Antimetabolites, Antineoplastic - administration & dosage | Neoadjuvant Therapy - mortality | Netherlands | Dose Hypofractionation | Time Factors | Deoxycytidine - adverse effects | Pancreatic Neoplasms - mortality | Pancreatectomy - adverse effects | Drug Administration Schedule | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - pathology | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Treatment Outcome | Tumor Burden | Adenocarcinoma - secondary | Pancreatectomy - mortality | Disease-Free Survival | Adenocarcinoma - therapy | Neoadjuvant Therapy - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Neoplasm Staging | Research Design | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Clinical trials | Care and treatment | Pancreaticoduodenectomy | Pancreatic cancer | Patient outcomes | Index Medicus
Journal Article